Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -72,636 | -48,001 | -23,908 | -88,853 | -67,054 |
| Depreciation Amortization | 388 | 142 | 169 | 896 | 682 |
| Income taxes - deferred | 102 | 68 | 34 | 23 | 102 |
| Accounts payable and accrued liabilities | 798 | 701 | 630 | -367 | -782 |
| Other Working Capital | -869 | -2,234 | -4,303 | 4,381 | 122 |
| Other Operating Activity | 9,124 | 6,004 | 2,938 | 13,904 | 11,498 |
| Operating Cash Flow | $-63,093 | $-43,320 | $-24,440 | $-70,016 | $-55,432 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 51,959 | 27,459 | 1,959 | -12,368 | 81,980 |
| PPE Investments | N/A | N/A | N/A | -42 | -42 |
| Investing Cash Flow | $51,959 | $27,459 | $1,959 | $-12,410 | $81,938 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 398 | 398 | 74 | 164,383 | 163,766 |
| Other Financing Activity | -6 | -6 | -6 | -388 | -75 |
| Financing Cash Flow | $392 | $392 | $68 | $163,995 | $163,691 |
| Exchange Rate Effect | 1 | -4 | -3 | -56 | 13 |
| Beginning Cash Position | 161,439 | 161,439 | 161,439 | 79,926 | 79,926 |
| End Cash Position | 150,698 | 145,966 | 139,023 | 161,439 | 270,136 |
| Net Cash Flow | $-10,741 | $-15,473 | $-22,416 | $81,513 | $190,210 |
| Free Cash Flow | |||||
| Operating Cash Flow | -63,093 | -43,320 | -24,440 | -70,016 | -55,432 |
| Capital Expenditure | N/A | N/A | N/A | -42 | -42 |
| Free Cash Flow | -63,093 | -43,320 | -24,440 | -70,058 | -55,474 |